Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 26, 2021

View Archived Issues

Sangamo presents IL23R-CAR-Tregs for treating Crohn's disease

Therapeutic profiling unveils three functional subtypes of cancer-associated fibroblasts in NSCLC

The gut microbiota affects CRPC growth by contributing to androgen metabolism

New human SARS-CoV-2 vaccines based on AAV vectors presented

CS-5001, novel ADC with promising efficacy in models of ROR1-expressing cancers

Repurposing bumetanide for the treatment of APOE4-related AD

Janssen BioPharma presents compounds for inhibiting respiratory syncytial virus replication

Thomas Jefferson University, Context Therapeutics patent androgen and SIGMAR1 receptor antagonists

New CD80/PD-L1 and/or PD-1/PD-L1 interaction inhibitors discovered at Bristol Myers Squibb

New HLA-DRB1 ligands identified at Janssen Pharmaceutica

Kinsensus Limited describes new MERTK/AXL inhibitors

AKAP11 identified as shared risk gene in bipolar disorder and schizophrenia

Gluk2-targeted siRNA-based gene therapy for drug-resistant temporal lobe epilepsy

Trivalent COVID-19 vaccine candidates do not require refrigeration, could be self-administered

Oxytocin receptor hypermethylation tied to obsessive-compulsive disorder

Tremeau to develop novel deuterium-enriched etoricoxib compound for acute pain

AstraZeneca compound shows activity against triple-mutant EGFR

Impaired axon guidance is early sign of Wolfram syndrome

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...